M&A Deal Summary |
|
---|---|
Date | 2019-10-22 |
Target | ACTT Allergy Testing |
Sector | Consumer Services |
Buyer(s) | Nextmune |
Sellers(s) | ALK Technologies |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Nextmune is a science-driven, global specialty pharmaceutical company focused on providing allergy diagnostics and allergy treatment of companion animals. Nextmune is based in Stockholm, Sweden.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Consumer Services) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New York) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2019) | 1 of 1 |
ALK Technologies, Inc., is a provider in routing, mapping, mileage and navigation technologies. ALK Technologies offers proprietary routing and international map-based solutions for transportation, logistics and mobile workforces.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Consumer Services) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New York) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2019) | 1 of 1 |